Faster and cheaper: Central European CRO

Bioforum reports in January 2012:

“In my opinion as well as in the opinion of  other professionals conducting clinical researches, CEE countries guarantee effective recruitment sufficient number of patients, high quality of data and cost effectiveness both for innovative products as well as for biosimilars. A key to success is a though, proper process of feasibility and individual planning for each trial” - points out Mariusz Olejniczak, General Manager (Poland) and Chief Operating Officer - Late Stage Projects, Assign Group.

for more info see: http://www.cebioforum.com/index.php?option=com_content&view=article&id=37:faster-and-cheaper-central-european-cro-market&catid=14:hot-news&Itemid=126